The newsroom includes access to CHA News, which provides timely information to members every Thursday and is at the core of CHA benefits. In addition, it is also home to resources such as toolkits and talking points designed to help member hospitals and health systems communicate with internal and external audiences on a range of current health care-related issues. Links to CHA media statements and press releases can also be found here.
Newsroom
CMS Issues CY 2022 OPPS Final Rule, Increases Price Transparency Penalties
On Nov. 2, the Centers for Medicare & Medicaid Services (CMS) finalized Medicare payment rates for hospital outpatient and ambulatory surgical center (ASC) services. CMS estimates that Medicare expenditures under the outpatient prospective payment system (OPPS) will increase by $1.3 billion based on changes in the final rule.
CMS Issues CY 2022 Physician Fee Schedule Final Rule
The Centers for Medicare & Medicaid Services (CMS) issued its calendar year (CY) 2022 physician fee schedule (PFS) final rule on Nov. 2.
CMS Issues 2022 Home Health Prospective Payment System Final Rule
The Centers for Medicare & Medicaid Services (CMS) has issued the final rule for the home health prospective payment system (PPS) for calendar year (CY) 2022.
Updates for the Week of Nov. 1
The Centers for Medicare & Medicaid Services issued the following updates this week:
CMS Issues Final Rule on CY 2022 End-Stage Renal Disease Prospective Payment System
The Centers for Medicare & Medicaid Services (CMS) has issued its final rule updating the end-stage renal disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2022. In addition to ESRD PPS payment rates updates, the rule includes changes to the ESRD Quality Incentive Program (QIP) and to the ESRD Treatment Choices Model to address health equity. The rule is effective Jan. 1, 2022. CMS finalizes an ESRD PPS base rate of $257.90...
CHA Alert Urges Representatives to Ensure Congressional Intent in Implementation of No Surprises Act
CHA encourages hospital leaders to continue to urge their representatives to sign on to a bipartisan letter to the Departments of Health and Human Services, Treasury, and Labor. The alert asks the agencies to correct the independent dispute resolution process included in the second No Surprises Act interim final rule. The deadline to sign on to the letter has...
FDA Authorizes Pediatric COVID-19 Vaccines, CDC Advisers Meet this Week
The U.S. Food and Drug Administration (FDA) has authorized the emergency use of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11. The Pfizer-BioNTech COVID-19 vaccine for children in this age group is administered as a two-dose primary series, three weeks apart, but is a lower dose (10 micrograms) than that used for ages 12 older (30 micrograms). The Centers for Disease Control and Prevention (CDC)...
Communications Roundup
CHA communications highlights for October include:

